Innovating Works
variaTECT: A novel genetic assay for risk assessment of cognitive decline in Alzheimer s Disease CYTOX LIMITED tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Alzheimer’s Disease (AD) is the most prevalent cognitive disorder and progressively leads to complete brain dysfunction and degeneration. Th...
2019-04-11 - 2019-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.